522 related articles for article (PubMed ID: 35113728)
1. Comparative study of six SARS-CoV-2 serology assays: Diagnostic performance and antibody dynamics in a cohort of hospitalized patients for moderate to critical COVID-19.
Chamkhi S; Dhaouadi T; Sfar I; Mokni S; Jebri A; Mansouri D; Ghedira S; Ben Jemia E; Ben Boujemaa S; Houissa M; Aouina H; Ben Abdallah T; Gorgi Y
Int J Immunopathol Pharmacol; 2022; 36():20587384211073232. PubMed ID: 35113728
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays.
Harley K; Gunsolus IL
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33106364
[TBL] [Abstract][Full Text] [Related]
3. A comparison of SARS-CoV-2 nucleocapsid and spike antibody detection using three commercially available automated immunoassays.
Poore B; Nerenz RD; Brodis D; Brown CI; Cervinski MA; Hubbard JA
Clin Biochem; 2021 Sep; 95():77-80. PubMed ID: 34118242
[TBL] [Abstract][Full Text] [Related]
4. Antibody tests for identification of current and past infection with SARS-CoV-2.
Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
[TBL] [Abstract][Full Text] [Related]
5. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y
J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Two Automated Immunoassays for the Detection of SARS-CoV-2 Nucleocapsid Antibodies.
Hubbard JA; Geno KA; Khan J; Szczepiorkowski ZM; de Gijsel D; Ovalle AA; AlSalman AS; Gallagher TL; Johnston AA; Tibbetts AR; Vital SE; Cervinski MA; Nerenz RD
J Appl Lab Med; 2021 Mar; 6(2):429-440. PubMed ID: 32976593
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Clinical Performance of 7 Serological Assays for SARS-CoV-2 for Use in Clinical Laboratories.
Plaga A; Wei R; Olson E; Payto D; Harrington J; Nwe-Kissig PT; Strizzi M; Zilka S; Ko J; Colón-Franco JM
J Appl Lab Med; 2021 Jul; 6(4):998-1004. PubMed ID: 33825844
[TBL] [Abstract][Full Text] [Related]
9. The role and diagnostic accuracy of serology for COVID-19.
Kundu D; Gautam P; Dayanand D; Gunasekaran K; Manesh A; Sebastian M; Abhilash KPP; Zachariah A; George T; Sathyendra S; Hansdak SG; Abraham OC; Iyadurai R; Thangakunam B; Gupta R; Karthik R; Moorthy M; Varghese GM
BMC Infect Dis; 2022 Apr; 22(1):390. PubMed ID: 35439957
[TBL] [Abstract][Full Text] [Related]
10. Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays.
Tan SS; Saw S; Chew KL; Huak CY; Khoo C; Pajarillaga A; Wang W; Tambyah P; Ong L; Jureen R; Sethi SK
Pathology; 2020 Dec; 52(7):770-777. PubMed ID: 33092816
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of three SARS-CoV2 antibody detection assays, neutralizing effect and longevity of serum antibodies.
Bubonja-Šonje M; Batičić L; Abram M; Cekinović Grbeša Đ
J Virol Methods; 2021 Jul; 293():114173. PubMed ID: 33930473
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and analytical performance evaluation of ten commercial assays for detecting SARS-CoV-2 humoral immune response.
Mylemans M; Van Honacker E; Nevejan L; Van Den Bremt S; Hofman L; Poels J; Cattoir L; Boel A; Van Hoovels L
J Immunol Methods; 2021 Jun; 493():113043. PubMed ID: 33773989
[TBL] [Abstract][Full Text] [Related]
13. Assessment of commercial SARS-CoV-2 antibody assays, Jamaica.
Butterfield TR; Bruce-Mowatt A; Phillips YZR; Brown N; Francis K; Brown J; Walker JP; McKnight NAL; Ehikhametalor K; Taylor DK; Bruce CA; McGrowder D; Wharfe G; Sandiford SL; Thompson TK; Anzinger JJ
Int J Infect Dis; 2021 Apr; 105():333-336. PubMed ID: 33610776
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
Front Public Health; 2020; 8():620222. PubMed ID: 33681115
[No Abstract] [Full Text] [Related]
15. Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories.
Harritshøj LH; Gybel-Brask M; Afzal S; Kamstrup PR; Jørgensen CS; Thomsen MK; Hilsted L; Friis-Hansen L; Szecsi PB; Pedersen L; Nielsen L; Hansen CB; Garred P; Korsholm TL; Mikkelsen S; Nielsen KO; Møller BK; Hansen AT; Iversen KK; Nielsen PB; Hasselbalch RB; Fogh K; Norsk JB; Kristensen JH; Schønning K; Kirkby NS; Nielsen ACY; Landsy LH; Loftager M; Holm DK; Nilsson AC; Sækmose SG; Grum-Schwensen B; Aagaard B; Jensen TG; Nielsen DM; Ullum H; Dessau RB
J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33574119
[TBL] [Abstract][Full Text] [Related]
16. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.
Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG
Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231
[TBL] [Abstract][Full Text] [Related]
17. Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan.
Chen SY; Lee YL; Lin YC; Lee NY; Liao CH; Hung YP; Lu MC; Wu JL; Tseng WP; Lin CH; Chung MY; Kang CM; Lee YF; Lee TF; Cheng CY; Chen CP; Huang CH; Liu CE; Cheng SH; Ko WC; Hsueh PR; Chen SC
Emerg Microbes Infect; 2020 Dec; 9(1):2157-2168. PubMed ID: 32940547
[TBL] [Abstract][Full Text] [Related]
18. Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain.
Poljak M; Oštrbenk Valenčak A; Štamol T; Seme K
J Clin Virol; 2021 Apr; 137():104784. PubMed ID: 33711693
[TBL] [Abstract][Full Text] [Related]
19. Anti-SARS-CoV-2 IgM improves clinical sensitivity early in disease course.
Higgins V; Fabros A; Wang XY; Bhandari M; Daghfal DJ; Kulasingam V
Clin Biochem; 2021 Apr; 90():1-7. PubMed ID: 33476578
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort.
Davidson N; Evans J; Giammichele D; Powell H; Hobson P; Teis B; Glover H; Guppy-Coles KB; Robson J
Pathology; 2020 Dec; 52(7):764-769. PubMed ID: 33070955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
